[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Jamie Murray posts on X about $pplto, $meta, meta, $lvmuy the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence stocks XXXX% technology brands XXXX% finance XXXX% countries XXXX% currencies XXXX%
Social topic influence $pplto 1.28%, $meta 1.28%, meta 1.28%, $lvmuy 1.28%, lvmh 1.28%, investment 1.28%, $atzto 1.28%, canada 1.28%, upside 1.28%, up the XXXX%
Top accounts mentioned or mentioned by @valuenotdeadyet @nuggetcapital @landryluc4 @kairospraxis @deepvalueco @inthemoneypod @stocktalk416 @baystreetamber @bnnbloomberg @mwgjamie @no_cap_cap @vanisleinvestor @beegjj @bizalmanac @capzay @leveragedlayman @bubleqe @compoundpapi @viggykrishnan @sidecarcap
Top assets mentioned Metadium (META) AstraZeneca PLC (AZN)
Top posts by engagements in the last XX hours
"$PPL.TO $META Kineticor close to announcing large datacenter - Pembina stock up 5%"
X Link @MWG_Jamie 2025-10-03T18:17Z 2661 followers, 11.8K engagements
"$LVMUY beats across the board"
X Link @MWG_Jamie 2025-10-14T15:51Z 2661 followers, 1145 engagements
"Some thoughts (opinions not investment advice) on $ATZ.TO post Q2. X. Oh Canada Yes the US shoots the lights out with XX% growth yoy but Canada was the upside surprise this Q. Aritzia sold as much per boutique in Q2 as they did in Q3 (Black Friday) last year. X. $ATZ.TO beat midpoint of guide by X% this Q. Average for past two years is closer to 5%. X. Company is operating on a new level (larger stores better marketing) with more to come (app international). Very clean quarter from a margin perspective too which bodes well despite tariff challenges. X. Stock needs to 'comp the comp' this Q4"
X Link @MWG_Jamie 2025-10-14T17:12Z 2662 followers, 2184 engagements
"What an iconic Blue Jays moment"
X Link @MWG_Jamie 2025-10-17T02:22Z 2662 followers, 2733 engagements
"$AZN great results for Enhertu Enhertu reduced the risk of disease recurrence or death by XX% vs. T-DM1 in patients with high-risk HER2-positive early breast cancer following neoadjuvant therapy in DESTINY-Breast05 Phase III trial"
X Link @MWG_Jamie 2025-10-18T15:47Z 2662 followers, XXX engagements